Package Leaflet: Information for the User
RESINSODIO Powder for Oral Suspension
Sodium Polystyrene Sulfonate
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the Package Leaflet
1. What RESINSODIO is and what it is used for
2. What you need to know before you take RESINSODIO
3. How to take RESINSODIO
4. Possible side effects
5. Storage of RESINSODIO
6. Contents of the pack and further information
RESINSODIO is presented as a powder for oral administration in multidose containers of 400 g.
Sodium polystyrene sulfonate is a drug that belongs to the group of medications used in the treatment of hyperkalemia and acts by decreasing the concentration of potassium ions in the blood.
RESINSODIO is used in:
Treatment and prevention of hyperkalemia (high levels of potassium in the blood).
Do not take RESINSODIO
Warnings and precautions
Consult your doctor or pharmacist before starting to use RESINSODIO
Using RESINSODIO with other medicines
Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines.
Tell your doctor if you take any of the following medicines, as they may interact with sodium polystyrene sulfonate, and it may be necessary to vary the dose or interrupt one of the treatments:
Taking RESINSODIO with food and drinks
It is not recommended to administer RESINSODIO with juices (due to their high potassium content).
Foods containing a sweetener called sorbitol should be avoided.
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medicine.
As there are no studies that provide conclusive data on the safety of using this medicine in pregnant women, the administration of RESINSODIO should be closely supervised by the doctor.
There are no studies that provide conclusive data on the safety of using this medicine in breastfeeding women. Therefore, the administration of RESINSODIO should be closely supervised by the doctor.
Driving and using machines
It is unknown whether the administration of sodium polystyrene sulfonate can alter the ability to drive vehicles or operate machines.
RESINSODIO Powder for Oral Suspension
This medicine contains 1.651 mg of sodium (the main component of table salt/cooking salt) in each 15 g dose unit. This is equivalent to 82.6% of the maximum daily sodium intake recommended for an adult. Consult your doctor or pharmacist if you need RESINSODIO for a prolonged period, especially if you have been recommended a low-salt diet (sodium).
This medicine contains a maximum of 35 mg of sodium benzoate (E-211) in each 15 g dose unit.
Follow exactly the administration instructions of this medicine indicated by your doctor. In case of doubt, consult your doctor or pharmacist again.
It is recommended to take RESINSODIO with sufficient water or sugared water.
The recommended dose is:
Recommended dose: administer 15 g of RESINSODIO three or four times a day suspended in water or sugared water.
Recommended dose:
Acute Hyperkalemia: The recommended dose is up to 1 g per kg of body weight per day, divided into several doses.
Maintenance: The recommended dose is 500 mg per kg of body weight per day, divided into several doses.
If you take more RESINSODIO than you should
If you take more RESINSODIO than you should, consult your doctor or pharmacist immediately, indicating the medicine and the amount ingested.
In case of overdose or accidental ingestion, consult the Toxicology Information Service. Phone (91) 562.04.20
If you forget to take RESINSODIO
Do not take a double dose to make up for forgotten doses.
If you stop taking RESINSODIO
If you have forgotten to take several doses, consult your doctor to indicate the dosage schedule to follow until you reach your maintenance dose.
If you have any other questions about the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Common (may affect up to 1 in 10 people):
Uncommon (may affect up to 1 in 100 people):
Rare (may affect up to 1 in 1,000 people):
Very rare (may affect up to 1 in 10,000 people):
Consult your doctor or nurse immediately if you notice any of the following serious side effects:
Reporting of side effects
If you experience any side effects, talk to your doctor or pharmacist, even if it is possible side effects not listed in this leaflet. You can also report side effects directly through the Spanish Pharmacovigilance System for Human Use Medicines: www.notificaRAM.es. By reporting side effects, you can help provide more information on the safety of this medicine.
No special storage conditions are required.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date stated on the container. The expiry date is the last day of the month indicated.
Medicines should not be disposed of via wastewater or household waste. Place the container and any unused medicine in the SIGRE point of the pharmacy. If in doubt, ask your pharmacist how to dispose of the container and any unused medicine. This will help protect the environment.
Composition of RESINSODIO
Appearance of the product and contents of the pack
RESINSODIO is a fine, golden or brown powder for oral suspension with a slight flavor and odor of vanilla.
It is presented in multidose containers of 400 g of powder.
Marketing authorization holder and manufacturer
LABORATORIOS RUBIO, S.A.
C/ Industria, 29. Pol. Ind. Comte de Sert,
08755 Castellbisbal (Barcelona) Spain
Date of the last revision of this leaflet: September 2023
Detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.es/
The average price of RESINSODIO POWDER FOR ORAL SUSPENSION in October, 2025 is around 29.69 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.